Generics - Teva Pharmaceutical Industries, Regulation

Filter

Popular Filters

EU approval for Teva’s DuoResp Spiromax for asthma and COPD

EU approval for Teva’s DuoResp Spiromax for asthma and COPD

30-04-2014

The European Commission has granted marketing authorization for Israel-based Teva Pharmaceutical Industries’…

DuoResp SpiromaxEuropeGenericsRegulationRespiratory and PulmonaryTeva Pharmaceutical Industries

Teva launches first generic Lovaza in USA

Teva launches first generic Lovaza in USA

08-04-2014

Israel-based Teva Pharmaceutical Industries says it has received US Food and Drug Administration approval…

Cardio-vascularGenericsGlaxoSmithKlineLovazaMarkets & MarketingRegulationTeva Pharmaceutical IndustriesUSA

Teva gains approval for generic Evista in the USA

Teva gains approval for generic Evista in the USA

04-03-2014

Israel-based Teva Pharmaceutical Industries says it has received approval from the US Food and Drug Administration…

Anti-Arthritics/RheumaticsEli LillyEvistaGenericsNorth AmericaRegulationTeva Pharmaceutical IndustriesUSA

US FDA approves first generic versions of antidepressant drug Cymbalta

US FDA approves first generic versions of antidepressant drug Cymbalta

12-12-2013

The US Food and Drug Administration yesterday approved the first generic versions of drug major Eli Lilly’s…

Aurobindo PharmaCymbaltaDr Reddy's LaboratoriesDuloxetine HclEli LillyGenericsLupinNeurologicalNorth AmericaRegulationSun Pharmaceutical IndustriesTeva Pharmaceutical Industries

Teva updates on Lonquex and Granix launches

Teva updates on Lonquex and Granix launches

18-11-2013

Israel-based Teva Pharmaceutical Industries announced two significant additions to its global oncology…

balugrastimBiosimilarsEuropeGenericsLonquexMarkets & MarketingNorth AmericaOncologyRegulationTeva Pharmaceutical Industries

US FDA approves Teva’s generic TOBI

US FDA approves Teva’s generic TOBI

14-10-2013

Teva Pharmaceutical Industries says that the US Food and Drug Administration has granted approval of…

Antibiotics and Infectious diseasesGenericsNovartisRare diseasesRegulationTeva Pharmaceutical IndustriesTobi

US FDA approves first generic Xeloda for colorectal and breast cancers

17-09-2013

The US Food and Drug Administration approved the first generic version of Swiss drug major Roche's (ROG:…

capecitabineGenericsNorth AmericaOncologyRegulationRocheTeva Pharmaceutical IndustriesXeloda

US FDA approves Lupin's generic version of Teva's Seasonique and Taro's Topicort

15-04-2013

Indian drugmaker Lupin (BSE: 500257) saw its shares gain 2.3% to 659.65 rupees by close of trading on…

DayseeDermatologicalsGenericsLupinMarkets & MarketingNorth AmericaPharmaceuticalRegulationReproductiveSeasoniqueTaro PharmaceuticalsTeva Pharmaceutical IndustriesTopicort

Actavis settles with Mallinckrodt over Exalgo 32mg; Teva gains FDA OK for Adderall XR

14-02-2013

US generics drug major Actavis (NYSE: ACT) has reached a settlement with Mallinckrodt (NYSE: MKG) on…

ActavisAdderall XRExalgoGenericsMallinckrodtNeurologicalNorth AmericaPatentsRegulationShireTeva Pharmaceutical Industries

Teva/Impax generic Wellbutrin XL 300mg pulled from US market on non-bioequivalence grounds

04-10-2012

Following a review of new data, the US Food and Drug Administration says these indicate that Budeprion…

Bupropion HclGenericsGlaxoSmithKlineImpax LaboratoriesNeurologicalNorth AmericaRegulationTeva Pharmaceutical IndustriesWellbutrin XL

FDA approves pediatric Afinitor from Novartis and Teva's tbo-filgrastim

30-08-2012

The US Food and Drug Administration yesterday approved Swiss drug major Novartis' (NOVN: VX) Afinitor…

AfinitorBiotechnologyGenericsNorth AmericaNovartisOncologyPharmaceuticalRegulationSicor Biotechtbo-filgrastimTeva Pharmaceutical Industries

Ranbaxy debuts authorized Actos generic in USA, followed by Teva and Mylan

20-08-2012

The US subsidiary of Ranbaxy Laboratories (AB: BO), India's largest drugmaker, has launched authorized…

ActoplusMetActosDiabetesGenericsMarkets & MarketingMylan LaboratoriesNorth AmericaRanbaxy LaboratoriesRegulationTakeda PharmaceuticalsTeva Pharmaceutical Industries

FDA approves first generic copies of Merck & Co's Singulair; and Pulmicort Respules

06-08-2012

The US Food and Drug Administration on Friday approved the first generic versions of Singulair (montelukast…

AstraZenecaGenericsMerck & CoMylan LaboratoriesNorth AmericaPulmicort RespulesRegulationRespiratory and PulmonarySandozSingulairTeva Pharmaceutical IndustriesWatson Pharmaceuticals

USA FDA approves ANDAs for Plan B One-Step and Trandate

16-07-2012

Watson Pharmaceuticals (NYSE: WPI) says its subsidiary Watson Laboratories approval from the US Food…

Cardio-vascularGenericsNorth AmericaPar PharmaceuticalsPlan B One-StepRegulationReproductiveTeva Pharmaceutical IndustriesTrandateWatson Pharmaceuticals

FDA delays once-a-day Prezista approval; finds counterfeit of Teva's Adderall

30-05-2012

US health care giant Johnson & Johnson's (NYSE: JNJ) Janssen Therapeutics division has received a complete…

AdderallAnti-viralsGenericsJanssenJohnson & JohnsonMarkets & MarketingNeurologicalNorth AmericaPharmaceuticalPrezistaRegulationTeva Pharmaceutical Industries

FDA decides Teva is sole first-to-file on Provigil; Mylan argues ruling

09-04-2012

Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA) said on April 5 that the US Food and Drug…

CephalonGenericsLegalModafinilMylan LaboratoriesNeurologicalNorth AmericaPar PharmaceuticalProvigilRegulationTeva Pharmaceutical Industries

Forest files suit over Bystolic patent; generic Lexapro launched in USA

15-03-2012

US drugmaker Forest Laboratories (NYSE: FRX) and Janssen Pharmaceutica, a unit of health care giant Johnson…

BystolicCardio-vascularForest LaboratoriesGenericsJanssen PharmaceuticaJohnson & JohnsonLexaproNeurologicalNorth AmericaPatentsRegulationTeva Pharmaceutical IndustriesWatson Pharmaceuticals

Teva gets BDP allergy drug NDA accepted by FDA; sued by ViiV over Epzicom

09-08-2011

The US Food and Drug Administration has accepted for filing Israeli generics giant Teva Pharmaceutical…

Anti-viralsEpzicomGenericsGlaxoSmithKlineLegalNorth AmericaPatentsPfizerPharmaceuticalRegulationRespiratory and PulmonaryTeva Pharmaceutical IndustriesViiV Healthcare

Teva gains EU approval for oral contraceptive Zoely

04-08-2011

There was good news for the world’s largest generics drugmaker Teva Pharmaceutical Industries (Nasdaq:…

EuropeGenericsPharmaceuticalRegulationReproductiveTeva Pharmaceutical IndustriesTheramexZoely

Back to top